News

The vaccine is intended to stimulate the immune system to fight the cancer cells while a PD-1 pathway inhibitor is designed to prevent the cancer cells from camouflaging

In this study, ZA-305, Androxal exhibited superiority in several assessments, particularly the two co-primary endpoints: percent change from baseline in average sperm concentration and percent of subjects considered

Both the companies will be responsible for jointly developing products which will be commercialized by Amerigen in the US. As part of the deal, Menovo will oversee manufacturing

Limitx is a new, early stage technology apart from the company’s other abuse deterrent technologies Aversion and Impede. The NIDA grant is based on a proposal submitted by

Velphoro, a non-calcium, iron-based, chewable phosphate binder, was issued a positive opinion in June 2014 by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use

Daklinza is approved for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 to treat HCV infection in adults. The combination of Daklinza

The randomized, double-blind, placebo-controlled trial is divided into two treatment arms, MN-166 and matching placebo, and includes a six-month treatment period followed by a six-month open-label extension. The

The grant was awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is a division of the National Institutes of Health (NIH). Patients suffering from IPF

The Phase IIa trial will include a total of seven experienced Alzheimer’s disease clinical trial sites in Melbourne. The company has submitted the clinical trial including the initiation